Crescent Biopharma Inc. has announced a new partnership with Sichuan Kelun-Biotech Biopharmaceutical...
Researchers from Crescent Biopharma Inc. and Paragon Therapeutics Inc. presented the preclinical dev...
Crescent Biopharma gains rights to a Kelun-Biotech antibody drug conjugate it plans to test in combi...
Cresent Biopharma, Inc. (NASDAQ:CBIO) shares were trading higher Thursday but have since reversed an...
Crescent Biopharma has agreed to pay Kelun-Biotech $80 million for ex-China rights to an antibody-dr...